Thymoma: a clinicopathological correlation of 1470 cases

Annikka Weissferdt, Neda Kalhor, Justin A. Bishop, Se Jin Jang, Jae Ro, Fredrik Petersson, Bingcheng Wu, Gerald Langman, Hollie Bancroft, Yalan Bi, Yunxiao Meng, Filomena Medeiros, Hans Brunnstrom, Dominic Spagnolo, Siaw Ming Chai, Andrew Laycock, Paul E. Wakely, Goran Elmberger, Fernando A. Soares, Antonio H. CamposDerya Gumurdulu, Isabel Alvarado-Cabrero, Domenico Coppola, Arlene M. Correa, David Rice, Reza J. Mehran, Boris Sepesi, Garrett Walsh, Larry Kaiser, Cesar A. Moran

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We present 1470 surgical resections for thymoma identified in the pathology files of 14 institutions from 11 countries with the purpose of determining and correlating a simplified histological classification of thymoma and pathological staging with clinical outcome. The study population was composed of 720 men and 750 women between the ages of 12 and 86 years (average, 54.8 years). Clinically, 137 patients (17%) had a history of myasthenia gravis, 31 patients (3.8%) of other autoimmune disease, and 55 (6.8%) patients of another neoplastic process. Surgical resection was performed in all patients. Histologically, 1284 (87.13%) cases were thymomas (World Health Organization types A, B1, and B2, and mixed histologies), and 186 (12.7%) were atypical thymomas (World Health Organization type B3). Of the entire group, 630 (42.9%) were encapsulated thymomas, and 840 (57.9%) were invasive thymomas in different stages. Follow-up information was obtained in 1339 (91%) patients, who subsequently were analyzed by univariate and multivariate statistical analysis. Follow-up ranging from 1 to 384 months was obtained (mean, 69.2 months) showing tumor recurrence in 136 patients (10.1%), whereas 227 died: 64 (28.2%) due to tumor and 163 (71.8%) due to other causes. Statistical analysis shows that separation of these tumors into thymoma and atypical thymoma is statistically significant (P =.001), whereas tumor staging into categories of encapsulated, minimally invasive, and invasion into adjacent organs offers a meaningful clinical assessment with a P =.038. Our findings suggest that our simplified histological schema and pathological staging system are excellent predictors of clinical outcome.

Original languageEnglish (US)
Pages (from-to)7-15
Number of pages9
JournalHuman Pathology
Volume73
DOIs
StatePublished - Mar 1 2018

Fingerprint

Thymoma
Neoplastic Processes
Neoplasms
Neoplasm Staging
Myasthenia Gravis
Autoimmune Diseases
Histology
Multivariate Analysis
Pathology
Recurrence

Keywords

  • Classification
  • Mediastinum
  • Staging
  • Thymoma
  • Thymus

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Weissferdt, A., Kalhor, N., Bishop, J. A., Jang, S. J., Ro, J., Petersson, F., ... Moran, C. A. (2018). Thymoma: a clinicopathological correlation of 1470 cases. Human Pathology, 73, 7-15. https://doi.org/10.1016/j.humpath.2017.08.018

Thymoma : a clinicopathological correlation of 1470 cases. / Weissferdt, Annikka; Kalhor, Neda; Bishop, Justin A.; Jang, Se Jin; Ro, Jae; Petersson, Fredrik; Wu, Bingcheng; Langman, Gerald; Bancroft, Hollie; Bi, Yalan; Meng, Yunxiao; Medeiros, Filomena; Brunnstrom, Hans; Spagnolo, Dominic; Chai, Siaw Ming; Laycock, Andrew; Wakely, Paul E.; Elmberger, Goran; Soares, Fernando A.; Campos, Antonio H.; Gumurdulu, Derya; Alvarado-Cabrero, Isabel; Coppola, Domenico; Correa, Arlene M.; Rice, David; Mehran, Reza J.; Sepesi, Boris; Walsh, Garrett; Kaiser, Larry; Moran, Cesar A.

In: Human Pathology, Vol. 73, 01.03.2018, p. 7-15.

Research output: Contribution to journalArticle

Weissferdt, A, Kalhor, N, Bishop, JA, Jang, SJ, Ro, J, Petersson, F, Wu, B, Langman, G, Bancroft, H, Bi, Y, Meng, Y, Medeiros, F, Brunnstrom, H, Spagnolo, D, Chai, SM, Laycock, A, Wakely, PE, Elmberger, G, Soares, FA, Campos, AH, Gumurdulu, D, Alvarado-Cabrero, I, Coppola, D, Correa, AM, Rice, D, Mehran, RJ, Sepesi, B, Walsh, G, Kaiser, L & Moran, CA 2018, 'Thymoma: a clinicopathological correlation of 1470 cases', Human Pathology, vol. 73, pp. 7-15. https://doi.org/10.1016/j.humpath.2017.08.018
Weissferdt, Annikka ; Kalhor, Neda ; Bishop, Justin A. ; Jang, Se Jin ; Ro, Jae ; Petersson, Fredrik ; Wu, Bingcheng ; Langman, Gerald ; Bancroft, Hollie ; Bi, Yalan ; Meng, Yunxiao ; Medeiros, Filomena ; Brunnstrom, Hans ; Spagnolo, Dominic ; Chai, Siaw Ming ; Laycock, Andrew ; Wakely, Paul E. ; Elmberger, Goran ; Soares, Fernando A. ; Campos, Antonio H. ; Gumurdulu, Derya ; Alvarado-Cabrero, Isabel ; Coppola, Domenico ; Correa, Arlene M. ; Rice, David ; Mehran, Reza J. ; Sepesi, Boris ; Walsh, Garrett ; Kaiser, Larry ; Moran, Cesar A. / Thymoma : a clinicopathological correlation of 1470 cases. In: Human Pathology. 2018 ; Vol. 73. pp. 7-15.
@article{69b0f6c699894ea6a39840d72c464597,
title = "Thymoma: a clinicopathological correlation of 1470 cases",
abstract = "We present 1470 surgical resections for thymoma identified in the pathology files of 14 institutions from 11 countries with the purpose of determining and correlating a simplified histological classification of thymoma and pathological staging with clinical outcome. The study population was composed of 720 men and 750 women between the ages of 12 and 86 years (average, 54.8 years). Clinically, 137 patients (17{\%}) had a history of myasthenia gravis, 31 patients (3.8{\%}) of other autoimmune disease, and 55 (6.8{\%}) patients of another neoplastic process. Surgical resection was performed in all patients. Histologically, 1284 (87.13{\%}) cases were thymomas (World Health Organization types A, B1, and B2, and mixed histologies), and 186 (12.7{\%}) were atypical thymomas (World Health Organization type B3). Of the entire group, 630 (42.9{\%}) were encapsulated thymomas, and 840 (57.9{\%}) were invasive thymomas in different stages. Follow-up information was obtained in 1339 (91{\%}) patients, who subsequently were analyzed by univariate and multivariate statistical analysis. Follow-up ranging from 1 to 384 months was obtained (mean, 69.2 months) showing tumor recurrence in 136 patients (10.1{\%}), whereas 227 died: 64 (28.2{\%}) due to tumor and 163 (71.8{\%}) due to other causes. Statistical analysis shows that separation of these tumors into thymoma and atypical thymoma is statistically significant (P =.001), whereas tumor staging into categories of encapsulated, minimally invasive, and invasion into adjacent organs offers a meaningful clinical assessment with a P =.038. Our findings suggest that our simplified histological schema and pathological staging system are excellent predictors of clinical outcome.",
keywords = "Classification, Mediastinum, Staging, Thymoma, Thymus",
author = "Annikka Weissferdt and Neda Kalhor and Bishop, {Justin A.} and Jang, {Se Jin} and Jae Ro and Fredrik Petersson and Bingcheng Wu and Gerald Langman and Hollie Bancroft and Yalan Bi and Yunxiao Meng and Filomena Medeiros and Hans Brunnstrom and Dominic Spagnolo and Chai, {Siaw Ming} and Andrew Laycock and Wakely, {Paul E.} and Goran Elmberger and Soares, {Fernando A.} and Campos, {Antonio H.} and Derya Gumurdulu and Isabel Alvarado-Cabrero and Domenico Coppola and Correa, {Arlene M.} and David Rice and Mehran, {Reza J.} and Boris Sepesi and Garrett Walsh and Larry Kaiser and Moran, {Cesar A.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1016/j.humpath.2017.08.018",
language = "English (US)",
volume = "73",
pages = "7--15",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Thymoma

T2 - a clinicopathological correlation of 1470 cases

AU - Weissferdt, Annikka

AU - Kalhor, Neda

AU - Bishop, Justin A.

AU - Jang, Se Jin

AU - Ro, Jae

AU - Petersson, Fredrik

AU - Wu, Bingcheng

AU - Langman, Gerald

AU - Bancroft, Hollie

AU - Bi, Yalan

AU - Meng, Yunxiao

AU - Medeiros, Filomena

AU - Brunnstrom, Hans

AU - Spagnolo, Dominic

AU - Chai, Siaw Ming

AU - Laycock, Andrew

AU - Wakely, Paul E.

AU - Elmberger, Goran

AU - Soares, Fernando A.

AU - Campos, Antonio H.

AU - Gumurdulu, Derya

AU - Alvarado-Cabrero, Isabel

AU - Coppola, Domenico

AU - Correa, Arlene M.

AU - Rice, David

AU - Mehran, Reza J.

AU - Sepesi, Boris

AU - Walsh, Garrett

AU - Kaiser, Larry

AU - Moran, Cesar A.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - We present 1470 surgical resections for thymoma identified in the pathology files of 14 institutions from 11 countries with the purpose of determining and correlating a simplified histological classification of thymoma and pathological staging with clinical outcome. The study population was composed of 720 men and 750 women between the ages of 12 and 86 years (average, 54.8 years). Clinically, 137 patients (17%) had a history of myasthenia gravis, 31 patients (3.8%) of other autoimmune disease, and 55 (6.8%) patients of another neoplastic process. Surgical resection was performed in all patients. Histologically, 1284 (87.13%) cases were thymomas (World Health Organization types A, B1, and B2, and mixed histologies), and 186 (12.7%) were atypical thymomas (World Health Organization type B3). Of the entire group, 630 (42.9%) were encapsulated thymomas, and 840 (57.9%) were invasive thymomas in different stages. Follow-up information was obtained in 1339 (91%) patients, who subsequently were analyzed by univariate and multivariate statistical analysis. Follow-up ranging from 1 to 384 months was obtained (mean, 69.2 months) showing tumor recurrence in 136 patients (10.1%), whereas 227 died: 64 (28.2%) due to tumor and 163 (71.8%) due to other causes. Statistical analysis shows that separation of these tumors into thymoma and atypical thymoma is statistically significant (P =.001), whereas tumor staging into categories of encapsulated, minimally invasive, and invasion into adjacent organs offers a meaningful clinical assessment with a P =.038. Our findings suggest that our simplified histological schema and pathological staging system are excellent predictors of clinical outcome.

AB - We present 1470 surgical resections for thymoma identified in the pathology files of 14 institutions from 11 countries with the purpose of determining and correlating a simplified histological classification of thymoma and pathological staging with clinical outcome. The study population was composed of 720 men and 750 women between the ages of 12 and 86 years (average, 54.8 years). Clinically, 137 patients (17%) had a history of myasthenia gravis, 31 patients (3.8%) of other autoimmune disease, and 55 (6.8%) patients of another neoplastic process. Surgical resection was performed in all patients. Histologically, 1284 (87.13%) cases were thymomas (World Health Organization types A, B1, and B2, and mixed histologies), and 186 (12.7%) were atypical thymomas (World Health Organization type B3). Of the entire group, 630 (42.9%) were encapsulated thymomas, and 840 (57.9%) were invasive thymomas in different stages. Follow-up information was obtained in 1339 (91%) patients, who subsequently were analyzed by univariate and multivariate statistical analysis. Follow-up ranging from 1 to 384 months was obtained (mean, 69.2 months) showing tumor recurrence in 136 patients (10.1%), whereas 227 died: 64 (28.2%) due to tumor and 163 (71.8%) due to other causes. Statistical analysis shows that separation of these tumors into thymoma and atypical thymoma is statistically significant (P =.001), whereas tumor staging into categories of encapsulated, minimally invasive, and invasion into adjacent organs offers a meaningful clinical assessment with a P =.038. Our findings suggest that our simplified histological schema and pathological staging system are excellent predictors of clinical outcome.

KW - Classification

KW - Mediastinum

KW - Staging

KW - Thymoma

KW - Thymus

UR - http://www.scopus.com/inward/record.url?scp=85042917306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042917306&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2017.08.018

DO - 10.1016/j.humpath.2017.08.018

M3 - Article

C2 - 28851660

AN - SCOPUS:85042917306

VL - 73

SP - 7

EP - 15

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

ER -